Pharma Développement

What Pharma Développement does

Pharma Développement is a privately held French industrial pharmaceutical laboratory founded in 1991 and headquartered in Corbigny, Bourgogne-Franche-Comté. The company manufactures and distributes a diversified portfolio of health products organized into four categories: medications spanning all major ATC therapeutic classes (digestive/metabolic, cardiovascular, dermatological, genito-urinary, hormones, anti-infectives, musculoskeletal, nervous system, respiratory, and blood/hematopoietic), dietary supplements, dermo-cosmetics and hygiene products, and food for special medical purposes including oral rehydration solutions. Manufacturing is anchored at a single Corbigny site holding ANSM GMP certification (reference 2022_HPF_FR_102) and includes specialized corticosteroid packaging workshops (since 2009) and a new dry forms production line commissioned in 2023.

The business operates as a Société par Actions Simplifiée (SAS) with €120,000 share capital, owned by Mario GIRON since 2008. The company sells through a multi-channel distribution model: French pharmacies for retail consumers, grossiste répartiteur and grossiste dépositaire (Movianto) for professional healthcare buyers, and a direct export team serving international markets. Products are commercially available in over 30 countries across Europe, Africa, the Americas, Caribbean, and Asia, with market entries sequenced from the United States (2009) through Francophone Africa (2012), Vietnam (2014), Iraq (2015), Algeria (2016), and Thailand (2020).

The customer base is structurally fragmented across retail pharmacies, wholesale distributors, and export channels, with no single anchor buyer identified. Marketing is limited to an institutional website and basic social media presence on LinkedIn, Facebook, and Instagram. The company reports 69 employees as of 2022 and states teams are growing. Revenue, funding history, and detailed pricing are not publicly disclosed.

Name

Pharma Développement

Legal name

PHARMA développement Société par Actions Simplifiée

Website

https://pharmadeveloppement.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Short description

Pharma Développement is a French GMP-certified pharmaceutical laboratory manufacturing medications, dietary supplements, dermo-cosmetics, and foods for special medical purposes, distributed through pharmacies and wholesalers in France and across more than 30 international markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

akta.pro secondary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Dermo-cosmetic products
• Dietary supplements
• Medical nutrition foods

Headquarters

HQ city

Corbigny

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products: Sale of medications, dietary supplements, dermo-cosmetics, hygiene products, dietary products, and food for special medical purposes through pharmacy distribution channels in France and internationally.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Pharma Développement is an industrial pharmaceutical laboratory that manufactures and distributes a broad portfolio of medications (covering ATC classes A, B, C, D, G, H, J, M, N, R), dietary supplements, dermo-cosmetics and hygiene products, dietary products, and food for special medical purposes. Products are sold through pharmacy distribution networks in France and exported to over 30 countries across Europe, Africa, the Americas, the Caribbean, and Asia. The company holds GMP certification from ANSM and operates corticosteroid packaging and dry forms production capabilities at its Corbigny facility.

Product overview

Pharma Développement is an industrial pharmaceutical laboratory founded in 1991, located in Corbigny, Burgundy-Franche-Comté, France. The company manufactures and distributes a diversified portfolio of health products across France and internationally. The product portfolio comprises four main categories: (1) Medications covering therapeutic areas including ATC A (Digestive/Metabolism - e.g., A 313, DIAMENIL, HYDROSOL POLYVITAMINÉ), ATC B (Blood/Hematopoietic - e.g., HEMOFER, RIVAROXI), ATC C (Cardiovascular - e.g., BISOBLOC, METOSSOR), ATC D (Dermatological - e.g., DERMO 6, CORTIGÉN), ATC G (Genito-urinary - e.g., CANDISTAT, DUTAS), ATC H (Hormones - e.g., PREDNABENE), ATC J (Anti-infectives - e.g., ELISOR, ULTRAVIR), ATC M (Musculoskeletal - e.g., ALGESAL BAUME, DOLFLAM), ATC N (Nervous system - e.g., BAPENTI, ESPRO), and ATC R (Respiratory - e.g., LEVOTEK, LORICIDIN); (2) Dietary supplements including ATIVIT PLUS, D3, MARINOL, Z+, CAMIWAY, SEL D, and XAL; (3) Dermo-cosmetics and hygiene products such as A 313 CREME COSMETIQUE, ACALMICINE, LACTAMOUSSE FEMME, and NAZINETTE DU DOCTEUR GILBERT; (4) Food for special medical purposes including YDROVIT/HYDROVIT (oral rehydration solutions). Products are distributed in France (metropolitan, overseas, Monaco) and internationally across Europe, Africa, the Americas, Asia, and the Caribbean.

Differentiator

Problem solved

Functional benefit

Products and services

• ACYPHINA Medication indicated for the treatment of erosive reflux esophagitis, excess stomach acid due to Zollinger-Ellison syndrome, and continuation of treatment after IV prevention of duodenal-gastric ulcer hemorrhagic recurrence.
• ATIVIT Medication indicated for the treatment of constitutional anorexia and emaciation.
• DIAMENIL / DIAMENIL LP / DIAMENIL V / DIAMENAX / GLUTRIL / REPAG / SITADIN / SITADIN M / ENCYCAZ Range of oral antidiabetic medications (including metformin and DPP-4 inhibitor variants) indicated for the treatment of type 2 diabetes in adults, with extended-release and standard formulations.
• DEXGASTRO / ULGAS / PROGASTRIC / GASTROKIT / MOVILIB / NAULE / FIBRA-FLAT / PORLAX / REDUFIT Range of medications for gastroesophageal reflux, peptic ulcers, H. pylori eradication, irritable bowel syndrome, nausea, constipation, hepatic encephalopathy, and overweight/obesity treatment.
• CAL-D / HYDROSOL POLYVITAMINÉ Pharma Développement / HEMOFER / NIS Medications and nutritional preparations for calcium and vitamin D deficiency, vitamin supplementation, iron and vitamin deficiency anemias, and candidiasis treatment.
• PREVERT / RIVAROXI / BISOBLOC / BISOCOR / CORVAN / DIOSMIL / ISTIN / LODAL / METOSSOR / SIROS Cardiovascular medications including anticoagulants, antihypertensives, beta-blockers, ACE inhibitors, calcium channel blockers, statins, and venotonics for conditions such as atrial fibrillation, hypertension, angina, heart failure, thromboembolism, and hypercholesterolemia.
• CORTIGÉN / DERMO 6 / ISOCNE / NOVASIL H / NOVASIL S Topical dermatological medications (corticosteroids, anti-acne agents, anti-inflammatory preparations) for irritant dermatoses, seborrheic conditions, severe acne, and corticosteroid-sensitive skin conditions.
• CANDISTAT 2% / CANDISTAT V / DAPWIN / DUTAS / FERMET / TAMDUS D / TAMLESS / TAMSU Medications for vaginal candidiasis, trichomoniasis, premature ejaculation, benign prostatic hyperplasia, and erectile dysfunction.
• PREDNABENE Systemic corticosteroid for anti-inflammatory indications.
• ALBIL / ELISOR / FLUCOLENE / GLOBACIN / ITRADERMA / KLARISTAT / LEVOSTAT / MIDAZOLE / PHESTAL / SORIFLOX / ULTRAVIR / ZYTROM Anti-infective medications including antibiotics, antifungals, antivirals, and antiparasitic agents for bacterial, fungal, viral, and parasitic infections across multiple therapeutic indications.
• ALGESAL BAUME / ALGESAL SURACTIVE / ATRICOX / DOLFLAM / IPROFENE / NAP / PHEST / QUENIL Anti-inflammatory and analgesic medications for musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, muscular and tendino-ligamentary pain, and inflammatory rheumatism.
• BAPENTI / DHOLO-PAX D / DOLENFANT / ESPRO / IBUFENE / LEVATIR / LIPRA / MYGESIC / NEUROLESS / PACETAM / PIPRAN / REDOL / NEURONERVAL Nervous system medications including anticonvulsants, analgesics, antidepressants, anxiolytics, and treatments for neurological conditions such as epilepsy, neuropathic pain, depression, anxiety disorders, and vitamin B deficiency-related neurological symptoms.
• LEVOTEK / LORICIDIN / PHYLLIN Respiratory medications including antihistamines for allergic rhinitis and chronic urticaria, and bronchodilators/theophylline derivatives for asthma and chronic obstructive bronchopulmonary diseases.
• A 313 50 000 U.I. / A 313 200 000 U.I. / ALCAPHOR Medications sold in France including vitamin A preparations for curative treatment of vitamin A deficiency and dermatological use, plus alkalinizing agent for prevention of uric acid and cystine lithiasis.
• Ydrovit / Hydrovit Oral rehydration solution (ORS) for compensating water and mineral losses; available in natural and peach flavors. Classified as a food for special medical purposes.
• Camiway / Sel D / Xal Dietary supplements sold in France including an infant colic/digestive comfort formulation, low-sodium dietary salt, and a sodium-free dietary salt.
• Lactamousse Femme / Nazinette du Docteur Gilbert (Baume Hiver / Baume Pectoral) Dermo-cosmetic and hygiene products sold in France including a daily intimate hygiene product and respiratory balms (nasal balm with essential oils and chest balm with camphor, menthol, and essential oils).
• Ativit Plus / D3 / Marinol / Z+ Dietary supplements sold internationally including a polyvitamin formulation, vitamin D3 supplement, phosphorus and calcium supplement (reformulation in progress), and a zinc-based immune support supplement.
• A 313 Crème Cosmétique / Acalmicine Dermo-cosmetic products sold internationally including a cutaneous protector containing synthetic vitamin A and a preparation for first and second degree burns and non-infected wounds.

Quantifiable outcome

• Professional equality index: 96/100

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• MoviantocoreChannel Partner/ Reseller/ DistributorMovianto serves as grossiste dépositaire (depositary wholesaler) for Pharma Développement products in France. Healthcare professionals can purchase products through Movianto, which handles logistics and invoicing.
• Grossiste répartiteur (Wholesale distributors)coreChannel Partner/ Reseller/ DistributorFrench wholesale distributors serve as primary channel for healthcare professionals to purchase Pharma Développement products.

Scale indicators4 records

Recent moves16 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Pharma-Développement-840807476011280
• LinkedInlinkedin.com/company/pharma-d-veloppement/?originalSubdomain=fr
• Instagraminstagram.com/pharmadeveloppement

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Développement